Importance Medications that influence the risk of dementia in the elderly can be relevant for
dementia prevention. Proton pump inhibitors (PPIs) are widely used for the treatment of …

Abstract Background Proton pump inhibitors (PPIs) are commonly prescribed for the
treatment of acid-related disorders. In the context of coronary artery disease (CAD), PPIs are …

Introduction Immune checkpoint inhibitors (ICI) is a rapidly evolving treatment modality for
stage IV non-small cell lung cancer (NSCLC). Concomitant proton pump inhibitor (PPI) use …

Objective To examine the risk of community acquired pneumonia before and after
prescription of proton pump inhibitor (PPI) and assess whether unmeasured confounding …

Background and Aim A growing body of literature suggests the association between
dementia risk and proton pump inhibitor (PPI) use. Therefore, we aimed to investigate the …

Purpose To analyse the prevalence of long‐term use of proton pump inhibitors (PPI) with
respect to underlying diseases and drugs, and to find predictors for such treatment when an …

Background The gut microbiome can mediate the efficacy of immune checkpoint inhibitors
(ICI). Meanwhile, proton pump inhibitors (PPI) can modulate the gut microbiome …

Abstract Objectives In the United States, proton pump inhibitors (PPIs) are one of the most
commonly prescribed classes of drugs, but contemporary data on national-level utilization …

Recent studies have indicated an increased risk of dementia and Alzheimer's disease (AD)
among people who consume proton pump inhibitors (PPIs), but the results of those studies …

Objectives Proton pump inhibitors (PPIs) are commonly prescribed for prevention and
treatment of gastrointestinal conditions or for gastroprotection from other drugs. Research …